Discontinuing cholinesterase inhibitor vs continued cholinesterase inhibitor
Dropout due to lack of efficacy of trial medication or deterioration in overall medical condition · people with dementia
Discontinuing cholinesterase inhibitor showed no clear difference in dropout due to lack of efficacy of trial medication or deterioration… compared with continued cholinesterase inhibitor (low certainty).
1 finding from 1 review
- Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia 2021 · Cochrane Headline outcomes onlyOR 1.53 [0.84, 2.76]4 studies · 583 participantsLow